Abbott Laboratories has underperformed the Nasdaq over the past year, but analysts are highly optimistic about the stock’s ...

Abbott (ABT) ended the recent trading session at $115.29, demonstrating a +2.74% change from the preceding day's closing price. The stock outperformed the S&P 500, which registered a daily loss of ...

On March 6, the American Ballet Theatre’s African American principal dancer, Calvin Royal III, launches the company’s spring 2026 season.

The three-row SUV arena is one of the most competitive in the automotive industry, and for good reason. Their balance of ...

A major wrongful death lawsuit has been filed alleging defects in Abbott Laboratories' (NYSE:ABT) FreeStyle Libre 3 and Libre 3 Plus glucose monitoring systems. The claim links the products to seven ...

Both the Oura Ring and the Whoop wristband specialize in holistic health tracking while eschewing screens to minimize distractions. We dive into the details to help you decide which is the best fit ...

The Medical Devices and Established Pharmaceuticals segments drive high single-digit growth for Abbott. Check out why ABT ...

Under the agreement between the companies, Abbott will commercialize Novo Nordisk's semaglutide (Ozempic) under the brand ...

We present a rigorously screened list of 10 top closed-end funds, or CEFs, for income investors, offering an average 9.7% yield and -10% NAV discount. Read the full analysis here.

Extensior® is approved as an adjunct to diet and exercise for adults with type 2 diabetes and is a GLP-1 RA recognized for offering the broadest range of benefits for people with this condition.

The collaboration brings together Novo Nordisk’s global GLP-1 leadership and Abbott’s strong India footprint, helping more ...